Cargando…
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma
Autores principales: | Claveau, Jean-Sébastien, Savary Bélanger, Sophie, Ahmad, Imran, Delisle, Jean-Sébastien, De Guire, Vincent, Roy, Jean, LeBlanc, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733007/ https://www.ncbi.nlm.nih.gov/pubmed/34987163 http://dx.doi.org/10.1038/s41408-021-00600-6 |
Ejemplares similares
-
Young Myeloma Patients: A Systematic Review of Manifestations and Outcomes
por: Tanguay, Mégane, et al.
Publicado: (2023) -
Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma
por: Giguère, Amélie, et al.
Publicado: (2023) -
Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Claveau, Jean-Sébastien, et al.
Publicado: (2022) -
Dissecting racial disparities in multiple myeloma—clues from differential immunoglobulin levels
por: Bunce, C. M., et al.
Publicado: (2020) -
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)